| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung | 23 | 2020 | 10099 | 1.060 |
Why?
|
| Lung Diseases | 5 | 2020 | 1944 | 0.990 |
Why?
|
| Pemphigoid, Benign Mucous Membrane | 1 | 2022 | 113 | 0.770 |
Why?
|
| Pemphigoid, Bullous | 1 | 2022 | 110 | 0.720 |
Why?
|
| Lung Diseases, Interstitial | 3 | 2019 | 940 | 0.630 |
Why?
|
| Glycogen Storage Disease | 1 | 2018 | 41 | 0.620 |
Why?
|
| Sleep Apnea Syndromes | 4 | 2023 | 984 | 0.620 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2019 | 271 | 0.610 |
Why?
|
| Vital Capacity | 2 | 2019 | 996 | 0.600 |
Why?
|
| Periventricular Nodular Heterotopia | 2 | 2019 | 57 | 0.590 |
Why?
|
| Cystic Fibrosis | 3 | 2024 | 1295 | 0.590 |
Why?
|
| Respiratory Insufficiency | 5 | 2019 | 1241 | 0.580 |
Why?
|
| Expeditions | 1 | 2017 | 11 | 0.560 |
Why?
|
| Pandemics | 6 | 2023 | 8749 | 0.510 |
Why?
|
| Nerve Growth Factors | 3 | 2013 | 564 | 0.460 |
Why?
|
| GTP-Binding Proteins | 6 | 1997 | 947 | 0.410 |
Why?
|
| Asthma | 5 | 2023 | 6293 | 0.400 |
Why?
|
| Sleep Apnea, Obstructive | 6 | 2023 | 1899 | 0.400 |
Why?
|
| Down Syndrome | 4 | 2022 | 919 | 0.390 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2002 | 89 | 0.360 |
Why?
|
| Apnea | 2 | 2009 | 195 | 0.350 |
Why?
|
| Receptors, Cell Surface | 6 | 2005 | 2820 | 0.340 |
Why?
|
| Child | 30 | 2024 | 80960 | 0.330 |
Why?
|
| Child Restraint Systems | 1 | 2009 | 20 | 0.330 |
Why?
|
| Beds | 1 | 2009 | 48 | 0.330 |
Why?
|
| Hypoglossal Nerve | 3 | 2021 | 110 | 0.330 |
Why?
|
| Electric Stimulation Therapy | 3 | 2021 | 637 | 0.330 |
Why?
|
| Cough | 4 | 2021 | 598 | 0.320 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2019 | 1672 | 0.320 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3118 | 0.300 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3241 | 0.300 |
Why?
|
| Respiratory Mucosa | 2 | 2024 | 439 | 0.290 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 2006 | 192 | 0.290 |
Why?
|
| Bradycardia | 1 | 2009 | 305 | 0.290 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2013 | 2812 | 0.280 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2008 | 86 | 0.280 |
Why?
|
| Heart | 2 | 2017 | 4447 | 0.270 |
Why?
|
| Streptococcus agalactiae | 1 | 2008 | 337 | 0.270 |
Why?
|
| Infant Equipment | 1 | 2006 | 23 | 0.270 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3253 | 0.270 |
Why?
|
| Respiratory System Abnormalities | 1 | 2007 | 67 | 0.270 |
Why?
|
| Tretinoin | 3 | 2010 | 525 | 0.260 |
Why?
|
| Cell Division | 6 | 2004 | 4478 | 0.260 |
Why?
|
| Smad4 Protein | 2 | 2024 | 193 | 0.250 |
Why?
|
| Macrophages, Alveolar | 4 | 2014 | 415 | 0.240 |
Why?
|
| Respiration | 3 | 2019 | 1668 | 0.240 |
Why?
|
| Hepatopulmonary Syndrome | 1 | 2004 | 25 | 0.240 |
Why?
|
| Oxygen | 4 | 2009 | 4272 | 0.230 |
Why?
|
| Nephrotic Syndrome | 1 | 2008 | 381 | 0.220 |
Why?
|
| Phenyl Ethers | 3 | 2010 | 62 | 0.220 |
Why?
|
| Kidney | 5 | 2008 | 7058 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2004 | 1246 | 0.210 |
Why?
|
| Lactic Acid | 1 | 2008 | 1140 | 0.210 |
Why?
|
| Transcription Factors | 5 | 2013 | 12174 | 0.210 |
Why?
|
| Humans | 73 | 2024 | 768970 | 0.210 |
Why?
|
| Infant | 13 | 2024 | 36556 | 0.210 |
Why?
|
| Health Promotion | 1 | 2015 | 2210 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2002 | 4528 | 0.200 |
Why?
|
| Viral Load | 1 | 2021 | 3398 | 0.200 |
Why?
|
| Blister | 1 | 2022 | 88 | 0.200 |
Why?
|
| Posture | 1 | 2006 | 957 | 0.200 |
Why?
|
| Sleep Apnea, Central | 1 | 2023 | 88 | 0.200 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 5804 | 0.200 |
Why?
|
| Portal Vein | 1 | 2004 | 435 | 0.190 |
Why?
|
| Mesoderm | 2 | 2004 | 679 | 0.190 |
Why?
|
| Altitude Sickness | 1 | 2002 | 93 | 0.190 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2024 | 453 | 0.190 |
Why?
|
| DNA | 4 | 2013 | 7214 | 0.190 |
Why?
|
| Fomites | 1 | 2021 | 15 | 0.190 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5716 | 0.190 |
Why?
|
| Mannose-Binding Lectin | 2 | 2014 | 146 | 0.180 |
Why?
|
| Pulmonary Alveoli | 2 | 2018 | 665 | 0.180 |
Why?
|
| Mannose-Binding Lectins | 3 | 2005 | 101 | 0.170 |
Why?
|
| Bronchi | 1 | 2024 | 850 | 0.170 |
Why?
|
| Mutation | 8 | 2024 | 30266 | 0.170 |
Why?
|
| Child, Preschool | 14 | 2024 | 42683 | 0.170 |
Why?
|
| Growth Disorders | 3 | 2024 | 635 | 0.170 |
Why?
|
| Respiratory Tract Infections | 1 | 2008 | 1014 | 0.170 |
Why?
|
| Pulmonary Surfactants | 1 | 2000 | 169 | 0.170 |
Why?
|
| Staphylococcus aureus | 1 | 2008 | 1430 | 0.170 |
Why?
|
| Pulmonary Edema | 1 | 2002 | 409 | 0.170 |
Why?
|
| Spirometry | 1 | 2023 | 929 | 0.170 |
Why?
|
| Bacterial Infections | 1 | 2008 | 1397 | 0.170 |
Why?
|
| Intelligence | 1 | 2004 | 927 | 0.160 |
Why?
|
| Mucous Membrane | 1 | 2022 | 659 | 0.160 |
Why?
|
| Thrombolytic Therapy | 1 | 2008 | 2055 | 0.160 |
Why?
|
| Leukocytes | 2 | 2013 | 2034 | 0.160 |
Why?
|
| Adolescent | 19 | 2024 | 89244 | 0.160 |
Why?
|
| Biopsy | 2 | 2022 | 6805 | 0.150 |
Why?
|
| Diagnosis, Differential | 7 | 2019 | 13021 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2002 | 637 | 0.150 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 2 | 2011 | 44 | 0.150 |
Why?
|
| Pulmonary Medicine | 1 | 2020 | 223 | 0.150 |
Why?
|
| Carbon Dioxide | 2 | 2006 | 1149 | 0.150 |
Why?
|
| Aerosols | 1 | 2021 | 636 | 0.150 |
Why?
|
| Amino Acids | 1 | 2024 | 1716 | 0.150 |
Why?
|
| Proto-Oncogenes | 2 | 1995 | 322 | 0.150 |
Why?
|
| Epithelial Cells | 3 | 2024 | 3702 | 0.150 |
Why?
|
| Respiratory Sounds | 4 | 2021 | 702 | 0.140 |
Why?
|
| Lectins, C-Type | 3 | 2005 | 593 | 0.140 |
Why?
|
| Pediatrics | 4 | 2020 | 3628 | 0.140 |
Why?
|
| Chemoreceptor Cells | 1 | 1997 | 87 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2005 | 478 | 0.140 |
Why?
|
| Cell Adhesion Molecules | 1 | 2003 | 1614 | 0.140 |
Why?
|
| Receptors, Immunologic | 1 | 2003 | 1418 | 0.130 |
Why?
|
| Cell Movement | 3 | 2017 | 5216 | 0.130 |
Why?
|
| Respiratory Function Tests | 2 | 2019 | 1694 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 18068 | 0.130 |
Why?
|
| Influenza, Human | 2 | 2020 | 1542 | 0.130 |
Why?
|
| Failure to Thrive | 1 | 2017 | 140 | 0.130 |
Why?
|
| Lymphoid Tissue | 2 | 1996 | 446 | 0.130 |
Why?
|
| Developmental Disabilities | 1 | 2004 | 1520 | 0.130 |
Why?
|
| Bronchitis | 1 | 1996 | 194 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 492 | 0.120 |
Why?
|
| Steroids | 1 | 2000 | 938 | 0.120 |
Why?
|
| Smoking | 2 | 2021 | 9094 | 0.120 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 621 | 0.120 |
Why?
|
| Airway Obstruction | 2 | 2006 | 672 | 0.120 |
Why?
|
| Scopolamine Derivatives | 1 | 2014 | 24 | 0.120 |
Why?
|
| Pulmonary Embolism | 1 | 2008 | 2600 | 0.110 |
Why?
|
| Hypertension, Pulmonary | 3 | 2020 | 1601 | 0.110 |
Why?
|
| Apoptosis | 6 | 2014 | 9527 | 0.110 |
Why?
|
| Infant, Newborn | 8 | 2021 | 26428 | 0.110 |
Why?
|
| Bronchoscopy | 2 | 2018 | 914 | 0.110 |
Why?
|
| Polysomnography | 2 | 2019 | 1871 | 0.110 |
Why?
|
| Infection Control | 1 | 2021 | 985 | 0.110 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 1712 | 0.110 |
Why?
|
| Male | 29 | 2024 | 365203 | 0.110 |
Why?
|
| Coculture Techniques | 1 | 2017 | 1342 | 0.110 |
Why?
|
| Semaphorin-3A | 1 | 2013 | 39 | 0.110 |
Why?
|
| Laryngeal Edema | 1 | 1993 | 21 | 0.110 |
Why?
|
| DNA-Binding Proteins | 3 | 1995 | 9618 | 0.110 |
Why?
|
| Ephrin-B2 | 1 | 2013 | 40 | 0.110 |
Why?
|
| Ubiquinone | 1 | 2014 | 183 | 0.110 |
Why?
|
| Inflammation | 3 | 2017 | 10868 | 0.110 |
Why?
|
| Immediate-Early Proteins | 1 | 1995 | 444 | 0.100 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2017 | 391 | 0.100 |
Why?
|
| DNA Primers | 3 | 2005 | 2827 | 0.100 |
Why?
|
| Signal Transduction | 5 | 2004 | 23653 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2005 | 3592 | 0.100 |
Why?
|
| Cytokines | 2 | 2024 | 7453 | 0.100 |
Why?
|
| Radiography, Thoracic | 2 | 2017 | 1321 | 0.100 |
Why?
|
| Ataxia | 1 | 2014 | 307 | 0.100 |
Why?
|
| Animals | 31 | 2013 | 169335 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2008 | 4850 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2002 | 2433 | 0.100 |
Why?
|
| Facies | 2 | 2024 | 224 | 0.100 |
Why?
|
| LLC-PK1 Cells | 3 | 1997 | 125 | 0.100 |
Why?
|
| Cryptorchidism | 2 | 2024 | 153 | 0.100 |
Why?
|
| Hemangioma | 1 | 2017 | 727 | 0.100 |
Why?
|
| Lymphangioma | 1 | 2011 | 60 | 0.100 |
Why?
|
| Hand Deformities, Congenital | 2 | 2024 | 175 | 0.090 |
Why?
|
| Muscle Weakness | 1 | 2014 | 413 | 0.090 |
Why?
|
| Electrodes, Implanted | 1 | 2016 | 841 | 0.090 |
Why?
|
| Young Adult | 7 | 2024 | 60131 | 0.090 |
Why?
|
| Adenoidectomy | 1 | 1993 | 171 | 0.090 |
Why?
|
| Morphogenesis | 2 | 2007 | 747 | 0.090 |
Why?
|
| Trans-Activators | 1 | 2000 | 2858 | 0.090 |
Why?
|
| DNA Damage | 1 | 2021 | 2472 | 0.090 |
Why?
|
| Bronchial Diseases | 1 | 2011 | 151 | 0.090 |
Why?
|
| Mitochondrial Diseases | 1 | 2014 | 344 | 0.090 |
Why?
|
| Enzyme Activation | 6 | 2004 | 3588 | 0.090 |
Why?
|
| Pneumocystis | 3 | 2005 | 55 | 0.090 |
Why?
|
| Transfection | 7 | 2004 | 5763 | 0.090 |
Why?
|
| Lung Transplantation | 1 | 2020 | 1309 | 0.090 |
Why?
|
| Female | 23 | 2024 | 397515 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2004 | 3985 | 0.090 |
Why?
|
| Bronchodilator Agents | 1 | 2014 | 518 | 0.090 |
Why?
|
| Cells, Cultured | 7 | 2013 | 19023 | 0.090 |
Why?
|
| Influenza A virus | 1 | 2014 | 460 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 4413 | 0.090 |
Why?
|
| Cell Line | 7 | 2024 | 15604 | 0.090 |
Why?
|
| Papilloma | 1 | 2011 | 143 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 1667 | 0.080 |
Why?
|
| Body Fat Distribution | 1 | 2011 | 246 | 0.080 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2010 | 146 | 0.080 |
Why?
|
| Tonsillectomy | 1 | 1993 | 281 | 0.080 |
Why?
|
| Cyclic AMP | 1 | 1993 | 1469 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2004 | 474 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 1423 | 0.080 |
Why?
|
| Propranolol | 1 | 2011 | 493 | 0.080 |
Why?
|
| Pedigree | 1 | 2017 | 4545 | 0.080 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2004 | 3730 | 0.080 |
Why?
|
| Rats | 12 | 2010 | 23786 | 0.080 |
Why?
|
| Term Birth | 1 | 2009 | 140 | 0.080 |
Why?
|
| Endoscopy | 1 | 2019 | 1862 | 0.080 |
Why?
|
| Culture Media, Conditioned | 2 | 2008 | 521 | 0.080 |
Why?
|
| Immunity | 1 | 2014 | 1003 | 0.080 |
Why?
|
| Pleural Effusion | 1 | 2011 | 345 | 0.080 |
Why?
|
| Organ Culture Techniques | 2 | 2008 | 796 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 567 | 0.080 |
Why?
|
| Transcription, Genetic | 5 | 1995 | 7609 | 0.080 |
Why?
|
| Virulence Factors, Bordetella | 2 | 1999 | 154 | 0.070 |
Why?
|
| Lectins | 1 | 2010 | 490 | 0.070 |
Why?
|
| Hypopharynx | 1 | 2008 | 53 | 0.070 |
Why?
|
| Pertussis Toxin | 2 | 1999 | 176 | 0.070 |
Why?
|
| Herbicides | 2 | 2007 | 104 | 0.070 |
Why?
|
| Vaccination | 1 | 2020 | 3438 | 0.070 |
Why?
|
| Gene Expression | 3 | 2010 | 7603 | 0.070 |
Why?
|
| Ebolavirus | 1 | 2010 | 250 | 0.070 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2007 | 31 | 0.070 |
Why?
|
| Transportation | 1 | 2009 | 217 | 0.070 |
Why?
|
| Mice | 12 | 2013 | 82072 | 0.070 |
Why?
|
| Chest Pain | 2 | 2019 | 1101 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 4592 | 0.070 |
Why?
|
| Bronchiolitis | 1 | 1993 | 492 | 0.070 |
Why?
|
| Laryngeal Neoplasms | 1 | 2011 | 514 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2020 | 3591 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 11932 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2020 | 3628 | 0.070 |
Why?
|
| Pyloric Stenosis | 1 | 1986 | 28 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 9549 | 0.070 |
Why?
|
| Hemoptysis | 1 | 2008 | 152 | 0.070 |
Why?
|
| Hemosiderosis | 1 | 2007 | 66 | 0.070 |
Why?
|
| Culture Techniques | 2 | 2004 | 530 | 0.070 |
Why?
|
| Molecular Sequence Data | 7 | 2002 | 17629 | 0.070 |
Why?
|
| Schools | 2 | 2020 | 1498 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 8055 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2005 | 11 | 0.070 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2007 | 244 | 0.070 |
Why?
|
| Phenotype | 1 | 2024 | 16731 | 0.060 |
Why?
|
| Swine | 5 | 1997 | 5997 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2010 | 1687 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2005 | 5033 | 0.060 |
Why?
|
| Teratocarcinoma | 1 | 2005 | 16 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2008 | 2488 | 0.060 |
Why?
|
| rhoB GTP-Binding Protein | 1 | 2004 | 17 | 0.060 |
Why?
|
| Quality of Life | 3 | 2022 | 13510 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 4056 | 0.060 |
Why?
|
| Fetus | 3 | 2008 | 1882 | 0.060 |
Why?
|
| Virulence Factors | 1 | 2008 | 502 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 2015 | 2200 | 0.060 |
Why?
|
| Virulence | 1 | 2008 | 1298 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2022 | 41808 | 0.060 |
Why?
|
| Superoxides | 1 | 2005 | 389 | 0.060 |
Why?
|
| Echocardiography | 1 | 2017 | 5047 | 0.060 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2004 | 188 | 0.060 |
Why?
|
| Adult | 9 | 2024 | 223851 | 0.060 |
Why?
|
| Heart Defects, Congenital | 2 | 2019 | 4712 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 1996 | 1683 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2017 | 2474 | 0.060 |
Why?
|
| COS Cells | 2 | 2002 | 1135 | 0.050 |
Why?
|
| Genes, Reporter | 2 | 2010 | 1524 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12467 | 0.050 |
Why?
|
| Clubfoot | 1 | 2024 | 87 | 0.050 |
Why?
|
| Air Pressure | 1 | 2023 | 75 | 0.050 |
Why?
|
| Health Behavior | 1 | 2015 | 2649 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7460 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2009 | 2108 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2002 | 34 | 0.050 |
Why?
|
| Cell Polarity | 2 | 2017 | 639 | 0.050 |
Why?
|
| Disease Progression | 2 | 2018 | 13674 | 0.050 |
Why?
|
| Base Sequence | 6 | 1996 | 12430 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2006 | 1586 | 0.050 |
Why?
|
| Chemotaxis | 1 | 2005 | 600 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2008 | 977 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 1999 | 2683 | 0.050 |
Why?
|
| Butadienes | 1 | 2002 | 107 | 0.050 |
Why?
|
| Interleukin-13 | 1 | 2024 | 391 | 0.050 |
Why?
|
| Epithelium | 3 | 2010 | 1607 | 0.050 |
Why?
|
| Homeostasis | 1 | 2013 | 3347 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 693 | 0.050 |
Why?
|
| Emergency Service, Hospital | 2 | 2020 | 7957 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2001 | 94 | 0.050 |
Why?
|
| Endothelium, Vascular | 2 | 2013 | 4428 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 575 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 697 | 0.050 |
Why?
|
| Vena Cava, Inferior | 1 | 2004 | 463 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2024 | 4356 | 0.050 |
Why?
|
| Chronic Disease | 3 | 2020 | 9384 | 0.050 |
Why?
|
| Receptors, Somatostatin | 1 | 2001 | 138 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2002 | 368 | 0.040 |
Why?
|
| Communication | 1 | 2015 | 3908 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 1998 | 0.040 |
Why?
|
| Fetal Development | 1 | 2005 | 777 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2002 | 617 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2002 | 6086 | 0.040 |
Why?
|
| Implantable Neurostimulators | 1 | 2020 | 75 | 0.040 |
Why?
|
| Aortic Valve Prolapse | 1 | 2019 | 10 | 0.040 |
Why?
|
| Pneumonia | 1 | 2011 | 2164 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4862 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2018 | 22296 | 0.040 |
Why?
|
| Gene Library | 1 | 2002 | 1062 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2019 | 20776 | 0.040 |
Why?
|
| Hospitals, General | 1 | 2024 | 810 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2014 | 6512 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2024 | 1042 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2004 | 4939 | 0.040 |
Why?
|
| Aged | 2 | 2022 | 171786 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2022 | 54962 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2005 | 2492 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2010 | 3744 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2024 | 1079 | 0.040 |
Why?
|
| Gastroesophageal Reflux | 1 | 2006 | 836 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2004 | 8317 | 0.040 |
Why?
|
| Vasodilation | 1 | 2002 | 967 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2021 | 81903 | 0.040 |
Why?
|
| Hypertrophy | 2 | 1993 | 562 | 0.040 |
Why?
|
| Equipment Design | 1 | 2006 | 3530 | 0.040 |
Why?
|
| Causality | 1 | 2004 | 1256 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2005 | 8144 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2010 | 3070 | 0.040 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2017 | 64 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2007 | 14484 | 0.040 |
Why?
|
| Congenital Abnormalities | 1 | 2002 | 704 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2011 | 3982 | 0.040 |
Why?
|
| Respiratory System | 1 | 2000 | 565 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 1999 | 407 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 4168 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2013 | 3431 | 0.030 |
Why?
|
| New England | 1 | 2020 | 1058 | 0.030 |
Why?
|
| Nitriles | 1 | 2002 | 990 | 0.030 |
Why?
|
| Virus Internalization | 1 | 2020 | 503 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1997 | 205 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 36854 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2000 | 771 | 0.030 |
Why?
|
| Genes, Wilms Tumor | 1 | 1995 | 92 | 0.030 |
Why?
|
| Early Growth Response Protein 1 | 1 | 1995 | 133 | 0.030 |
Why?
|
| Massachusetts | 2 | 2024 | 8894 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2020 | 733 | 0.030 |
Why?
|
| Parents | 1 | 2009 | 3597 | 0.030 |
Why?
|
| WT1 Proteins | 1 | 1995 | 184 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1999 | 1207 | 0.030 |
Why?
|
| Brain | 2 | 2017 | 27453 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 395 | 0.030 |
Why?
|
| Pulmonary Artery | 2 | 1995 | 1945 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 1831 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1999 | 2298 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2017 | 660 | 0.030 |
Why?
|
| Syndrome | 1 | 2021 | 3274 | 0.030 |
Why?
|
| Seasons | 1 | 2020 | 1524 | 0.030 |
Why?
|
| Research Report | 1 | 2017 | 369 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2664 | 0.030 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2014 | 80 | 0.030 |
Why?
|
| World Health Organization | 1 | 2020 | 1328 | 0.030 |
Why?
|
| Gene Silencing | 3 | 2005 | 1505 | 0.030 |
Why?
|
| Travel | 1 | 2020 | 805 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2000 | 2003 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 941 | 0.030 |
Why?
|
| Environment | 1 | 2020 | 1122 | 0.030 |
Why?
|
| Pulmonary Emphysema | 1 | 2019 | 689 | 0.030 |
Why?
|
| Radiography | 2 | 1996 | 6991 | 0.030 |
Why?
|
| Culture Media | 1 | 1995 | 898 | 0.030 |
Why?
|
| U937 Cells | 1 | 2014 | 260 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2002 | 2149 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 1995 | 577 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 2014 | 313 | 0.030 |
Why?
|
| Adenoids | 1 | 1993 | 35 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 15951 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 2004 | 0.030 |
Why?
|
| Influenza Vaccines | 1 | 2020 | 781 | 0.030 |
Why?
|
| Heterozygote | 1 | 2019 | 2798 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1995 | 1647 | 0.030 |
Why?
|
| Palatine Tonsil | 1 | 1993 | 193 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1993 | 288 | 0.030 |
Why?
|
| Nucleosomes | 1 | 1996 | 492 | 0.030 |
Why?
|
| Immunity, Innate | 2 | 2020 | 3080 | 0.020 |
Why?
|
| Patient Preference | 1 | 2020 | 947 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 1994 | 5801 | 0.020 |
Why?
|
| Genotype | 2 | 2024 | 13048 | 0.020 |
Why?
|
| Receptors, GABA | 1 | 1994 | 312 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 22379 | 0.020 |
Why?
|
| Autonomic Nervous System | 1 | 1997 | 709 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2002 | 2682 | 0.020 |
Why?
|
| Dyspnea | 1 | 2019 | 1352 | 0.020 |
Why?
|
| Macrophage Activation | 2 | 2004 | 556 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 2 | 2002 | 420 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 3612 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2004 | 826 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 3726 | 0.020 |
Why?
|
| Snoring | 1 | 1993 | 211 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2007 | 11684 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 13427 | 0.020 |
Why?
|
| Nasal Obstruction | 1 | 1993 | 163 | 0.020 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 1996 | 1116 | 0.020 |
Why?
|
| Plasmids | 1 | 1995 | 2269 | 0.020 |
Why?
|
| Middle Aged | 4 | 2022 | 223737 | 0.020 |
Why?
|
| Epoprostenol | 1 | 1991 | 246 | 0.020 |
Why?
|
| Retinal Dehydrogenase | 1 | 2010 | 78 | 0.020 |
Why?
|
| Hyperplasia | 1 | 1993 | 1154 | 0.020 |
Why?
|
| Time Factors | 3 | 2006 | 40261 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2011 | 436 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1997 | 1611 | 0.020 |
Why?
|
| Gestational Age | 1 | 1999 | 3621 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 250 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 11116 | 0.020 |
Why?
|
| Abdominal Fat | 1 | 2011 | 221 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2010 | 272 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1999 | 3659 | 0.020 |
Why?
|
| Medicine | 1 | 2017 | 947 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2010 | 275 | 0.020 |
Why?
|
| Calreticulin | 1 | 2010 | 115 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1995 | 1493 | 0.020 |
Why?
|
| Multiple Organ Failure | 1 | 2011 | 387 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1994 | 3057 | 0.020 |
Why?
|
| Kinetics | 2 | 2010 | 6332 | 0.020 |
Why?
|
| Exercise | 2 | 2020 | 5954 | 0.020 |
Why?
|
| Liver | 1 | 2004 | 7578 | 0.020 |
Why?
|
| Obesity | 1 | 2011 | 13091 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 308 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2022 | 65480 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 2005 | 2087 | 0.020 |
Why?
|
| Chloramphenicol | 1 | 1988 | 67 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2020 | 2192 | 0.020 |
Why?
|
| Dysphonia | 1 | 2011 | 144 | 0.020 |
Why?
|
| Subcutaneous Fat | 1 | 2011 | 404 | 0.020 |
Why?
|
| HIV Infections | 2 | 2004 | 17591 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2009 | 615 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 18354 | 0.020 |
Why?
|
| Oxidation-Reduction | 2 | 2005 | 2226 | 0.020 |
Why?
|
| Voice | 1 | 2011 | 268 | 0.020 |
Why?
|
| Paresthesia | 1 | 1988 | 160 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 2010 | 738 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 13594 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 1836 | 0.020 |
Why?
|
| Ireland | 1 | 1986 | 170 | 0.020 |
Why?
|
| Recurrence | 2 | 2011 | 8513 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2013 | 3102 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7861 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 1999 | 12806 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2011 | 631 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 1081 | 0.020 |
Why?
|
| Optic Neuritis | 1 | 1988 | 175 | 0.020 |
Why?
|
| Drainage | 1 | 2011 | 1184 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2149 | 0.020 |
Why?
|
| Proteins | 1 | 2000 | 6011 | 0.020 |
Why?
|
| Physical Examination | 1 | 2011 | 1262 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2007 | 731 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 424 | 0.020 |
Why?
|
| Drug Design | 1 | 2010 | 1046 | 0.020 |
Why?
|
| Zymosan | 1 | 2004 | 134 | 0.010 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2007 | 337 | 0.010 |
Why?
|
| Neutrophils | 1 | 2017 | 3785 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2004 | 222 | 0.010 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2011 | 1027 | 0.010 |
Why?
|
| Organogenesis | 1 | 2005 | 214 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 14794 | 0.010 |
Why?
|
| p21-Activated Kinases | 1 | 2004 | 127 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 816 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 612 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2004 | 210 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2005 | 1163 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 1996 | 39394 | 0.010 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2004 | 279 | 0.010 |
Why?
|
| Glutathione Disulfide | 1 | 2002 | 32 | 0.010 |
Why?
|
| Feedback, Physiological | 1 | 2005 | 481 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2011 | 4040 | 0.010 |
Why?
|
| Telemedicine | 1 | 2020 | 3110 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 4568 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2004 | 761 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2005 | 705 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5375 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2005 | 633 | 0.010 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2002 | 93 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2001 | 43 | 0.010 |
Why?
|
| Fetal Organ Maturity | 1 | 2001 | 83 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 1904 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 2002 | 213 | 0.010 |
Why?
|
| Aging | 1 | 2020 | 8745 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 2002 | 262 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 17173 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3782 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 1408 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2002 | 331 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 14201 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 440 | 0.010 |
Why?
|
| Glutathione | 1 | 2002 | 589 | 0.010 |
Why?
|
| Somatostatin | 1 | 2001 | 458 | 0.010 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 1999 | 106 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 8559 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 1328 | 0.010 |
Why?
|
| Health Surveys | 1 | 2009 | 4055 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2004 | 1530 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1973 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 4940 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2005 | 2222 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3813 | 0.010 |
Why?
|
| Anemia | 1 | 2007 | 1517 | 0.010 |
Why?
|
| Actins | 1 | 2004 | 2065 | 0.010 |
Why?
|
| HIV-1 | 2 | 2004 | 6962 | 0.010 |
Why?
|
| Pregnancy | 1 | 1999 | 30265 | 0.010 |
Why?
|
| Neurons | 1 | 1996 | 9519 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 1933 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1996 | 421 | 0.010 |
Why?
|
| Amiloride | 1 | 1995 | 116 | 0.010 |
Why?
|
| Rats, Inbred WKY | 1 | 1995 | 150 | 0.010 |
Why?
|
| Rats, Inbred SHR | 1 | 1995 | 186 | 0.010 |
Why?
|
| Homozygote | 1 | 2000 | 1780 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2004 | 3433 | 0.010 |
Why?
|
| Hypertension | 1 | 1995 | 8617 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2004 | 2885 | 0.010 |
Why?
|
| Cell Survival | 1 | 2005 | 5793 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2007 | 3466 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 15471 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 1996 | 8760 | 0.010 |
Why?
|
| Antioxidants | 1 | 2002 | 1673 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 2911 | 0.010 |
Why?
|
| Clonazepam | 1 | 1994 | 135 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74976 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10765 | 0.010 |
Why?
|
| Down-Regulation | 1 | 1999 | 2942 | 0.010 |
Why?
|
| Luciferases | 1 | 1994 | 713 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1994 | 975 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2000 | 6236 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1993 | 1057 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1991 | 398 | 0.010 |
Why?
|
| Indomethacin | 1 | 1991 | 323 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1991 | 315 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 1990 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1994 | 792 | 0.010 |
Why?
|
| Temperature | 1 | 1995 | 2235 | 0.000 |
Why?
|
| Pyridoxine | 1 | 1988 | 109 | 0.000 |
Why?
|
| HeLa Cells | 1 | 1994 | 3076 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 26395 | 0.000 |
Why?
|
| Aorta | 1 | 1995 | 2046 | 0.000 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1994 | 1369 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1993 | 1965 | 0.000 |
Why?
|
| Vitamin B 12 | 1 | 1988 | 529 | 0.000 |
Why?
|
| Age Factors | 1 | 2000 | 18435 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1996 | 5151 | 0.000 |
Why?
|
| Amyloid beta-Peptides | 1 | 1996 | 3913 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 20245 | 0.000 |
Why?
|
| Visual Acuity | 1 | 1988 | 2714 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1994 | 5831 | 0.000 |
Why?
|